The leading theory in Alzheimer’s disease is that memory loss is the result of neuron death and nerve ending damage, which lead to memory…
Scientists looking for a new Alzheimer’s treatment have traditionally focused on the build-up of protein deposits such as beta-amyloid and tau in patients’ brains….
Being Patient meets John Gallacher, Professor of Cognitive Health at Oxford University and Director of the Dementias Platform UK (DPUK), to find out how…
The connection between music and Alzheimer’s is the subject of an increasing number of studies–some early evidence even points to music as a potential…
Here’s a quick look at a 2017 analysis of the Alzheimer’s drug pipeline. Twenty-seven Alzheimer’s drugs in Phase III clinical trials and eight drugs…
This week Being Patient was at the Alzheimer’s Association International Conference in London, where over 5000 leaders in dementia research gathered to discuss the latest thinking…
New research suggests that light therapy holds the potential to treat symptoms of dementia. In a new study, researchers have applied a type of…